FindTrial
Sign In

Tanito Microhook (TMH) Combined with Phacoemulsification for Primary Glaucoma: A Randomized Controlled Study

Tanito Microhook (TMH) Combined with Phacoemulsification for Primary Glaucoma: A Randomized Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057593
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-15
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Glaucoma

Interventions

PACG Clinical Trial Group :Phacoemulsification+IOL implantation combined with GSL and TMH using gonioscope
POAG Clinical Trial Group :Phacoemulsification+IOL implantation combined with TMH
Control Group:Phacoemulsification+IOL implantation combined with trabeculotomy

Sponsors

Changshu NO.2 People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with PACG complicated with cataract; 2. Patients with POAG complicated with cataract; 3. Best-corrected visual acuities <=0.5; 4. No contraindications for operation; 5. Providing written informed consent for surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with primary glaucoma complicated with cataract.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure (IOP);Best-corrected visual acuities (BCVA);IOP-lowering medication;—

Secondary

MeasureTime frame
Optic Disc's Rim;RNFL thickness;Visual Field Mean Deviation (MD);—

Countries

China

Contacts

Public ContactHuang Zhengru

Changshu NO.2 People’s Hospital

hzru@sina.com+86 13901578400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026